Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke (CLOTBUST-ER)
This study is currently recruiting participants.
Verified May 2013 by Cerevast Therapeutics, Inc.
Study NCT01098981
Information provided by Cerevast Therapeutics, Inc.
First Received on April 2, 2010.
Last Updated on May 14, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
